Table 2. Specific HBV mutations according to HBV patterns and genotypes.

ID	Sex	Age (yrs)	CD4 (/mL)	HIV-1 RNA (log)	ART duration (months)	HBV
						HBV DNA (log)	Pattern	GT	Viral mutations
									RAMs	VEM	BCP	PC
175	M	51	54	6.02	0	7.45	2	A	WT	WT	A1762T/G1764A	WT
329	F	40	499	3.19	60*	7.39	2	A	L180M, M204V	WT	WT	WT
2219	M	58	94	4.66	0	7.37	2	E	WT	WT	WT	WT
2709117	M	45	10	5.52	0	7.40	3a	E	WT	WT	WT	G1896A
MIMI	F	50	618	<1.24	4*	5.52	3a	A	WT	T126I	WT	G1896A
841	F	46	752	<1.24	98*	4.52	3a	A	WT	WT	WT	WT
2337	M	42	34	6.45	0	4.17	3a	A	WT	WT	WT	WT
2370	F	53	426	4.44	0	4.15	3a	E	WT	WT	A1762T/G1764A	G1896A
1213	M	40	666	3.42	67*	3.44	3a	E	WT	WT	nd	nd
2249	M	46	37	4.40	0	3.06	3b	E	WT	P120T	WT	WT
1341	F	36	618	<1.24	34*	3.02	3b	A	WT	WT	nd	nd
2543	M	40	266	<1.24	6**	2.94	3b	A	WT	WT	nd	nd
1543	F	49	318	5.21	30*	2.79	3b	A	L180M, M204V	WT	nd	nd
914	F	38	618	3.89	12*	2.52	3b	A	L180M, M204V	WT	nd	nd
2589	F	34	405	4.0	4**	2.47	3b	A	WT	WT	nd	nd
596	F	31	227	<1.24	53*	2.43	3b	A	WT	WT	WT	WT
2333	M	46	372	<1.24	11*	2.39	3b	E	WT	WT	A1762T/G1764A	G1896A
999	F	33	970	<1.24	58*	2.03	3b	A	L180M, M204V	WT	WT	WT
1956	F	30	258	nd	0	4.84	4a	A	L180M, M204V	WT	nd	nd
98	F	50	207	6.41	85*	4.41	4a	E	WT	WT	A1762T/G1764A	G1896A
1773	F	38	533	<1.24	21*	3.82	4a	A	L180M, M204I	WT	nd	nd
1576	M	35	533	3.09	0	3.50	4a	A	WT	WT	WT	G1896A
803	M	44	208	5.59	46*	2.80	4a	A	L180M/M204I	WT	nd	nd
2491	F	29	277	4.90	0	2.73	4a	A	L180M/M204I	WT	nd	nd
926	F	70	488	3.56	0	2.72	4a	A	L180M/M204V	WT	nd	nd
754	F	37	22	5.07	81*	2.69	4a	A	WT	WT	nd	nd
92	M	46	316	3.84	19**	2.63	4a	E	WT	WT	nd	nd
745	M	40	547	<1.24	32*	2.63	4a	E	WT	WT	nd	nd

*3TC-based ART;

**TDF-based ART.

Abbreviations: ART, antiretroviral treatment; F, female; M, male; GT, genotype; BCP, basal core promoter; PC, precore; WT, wild type; nd, not done.